Fig 1.
PRISMA flow chart.
Table 1.
Quality assessment of the studies included in the systematic review and meta-analysis.
Fig 2.
Global regions included in this study.
Table 2.
Characteristics of individual studies included in the current systematic and met-analysis.
Fig 3.
Forest plot for ESBL-PE colonization of hospitalized patients.
Fig 4.
Forest plot for CRE colonization rate of hospitalized patients.
Fig 5.
Forest plot for ESBL-producing E. coli.
Fig 6.
ESBL-producing K. pneumoniae.
Fig 7.
Forest plot showing the estimate of carbapenem producing K. pneumoniae.
Fig 8.
Forest plot showing the estimate of Carbapenem producing E.coli.
Fig 9.
Funnel plot showing publication biases.
Table 3.
Publication bias and egger’s test of ESBL-PE and CRE pooled estimates.
Fig 10.
Forest plot showing subgroup analysis of ESBL-PE in Asia, Europe and Africa.
Fig 11.
Forest plot of CRE colonization in Asia, Africa and Europe region.
Fig 12.
ESBL-PE subgroup analysis by study design.
Fig 13.
CRE subgroup analysis by study design.
Fig 14.
Pooled estimate of Multidrug resistant level.
Fig 15.
Forest plot of meta-analysis of ESBL-PE colonization with previous hospitalization.
Fig 16.
Forest plot for meta-analysis of hospital stay with ESBL-PE colonization.
Fig 17.
Odds ratio for ESBL colonization and previous antibiotics.
Fig 18.
Forest plot for carbapenem and CRE colonization.
Fig 19.
Forest plot for fluoroquinolone and CRE colonization.
Table 4.
Meta-analysis of association between comorbidities and ESBL-PE /CRE colonization.